|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 7/64 | |
| A61K 38/13 | |||
| A61P 27/02 |
| (11) | Number of the document | 2780358 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12791059.4 |
| Date of filing the European patent application | 2012-11-14 | |
| (97) | Date of publication of the European application | 2014-09-24 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/064985 |
| Date | 2012-11-14 |
| (87) | Number | WO 2013/074608 |
| Date | 2013-05-23 |
| (30) | Number | Date | Country code |
| 201161559830 P | 2011-11-15 | US |
| (72) |
WU, Ke, US
SMITH, Scott, W., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | CYCLOSPORINE A FORM 2 AND METHOD OF MAKING SAME |
| CYCLOSPORINE A FORM 2 AND METHOD OF MAKING SAME |